S. 934: FDA Reauthorization Act of 2017

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

The bill’s titles are written by its sponsor.

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.

What you can do

Overview

Introduced:

Apr 25, 2017

Status:

Ordered Reported by Committee on May 11, 2017

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on May 11, 2017.

Sponsor:

Lamar Alexander

Senior Senator from Tennessee

Republican

Text:

Read Text »
Last Updated: May 11, 2017
Length: 268 pages

Prognosis:

9% chance of being enacted according to Skopos Labs (details)

History

Apr 25, 2017
 
Introduced

This is the first step in the legislative process.

May 11, 2017
 
Ordered Reported by Committee

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

 
Passed Senate

 
Passed House

 
Signed by the President

S. 934 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 934 — 115th Congress: FDA Reauthorization Act of 2017.” www.GovTrack.us. 2017. May 24, 2017 <https://www.govtrack.us/congress/bills/115/s934>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.